| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/18/2002 | EP1241265A2 Screening assay for small ligands |
| 09/18/2002 | EP1241259A1 Peptide having pronociceptive properties |
| 09/18/2002 | EP1241256A1 Novel gene and use thereof |
| 09/18/2002 | EP1241255A1 Novel human rna helicase, helicain |
| 09/18/2002 | EP1241249A1 CD4+CD25+regulatory T cells from human blood |
| 09/18/2002 | EP1241186A2 Human growth arrest specific gene 6 (gas-6) and nucleic acids encoding the same |
| 09/18/2002 | EP1240922A2 Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 09/18/2002 | EP1240528A2 Hematological assay and reagent |
| 09/18/2002 | EP1240526A2 Conformational and topological protein regulation |
| 09/18/2002 | EP1240522A2 Light-emitting particles for diagnostic and therapeutic use |
| 09/18/2002 | EP1240521A2 Identification of disease markers involving mass-based-separation |
| 09/18/2002 | EP1240520A2 Kit and method to assess the malignancy of neoplasias |
| 09/18/2002 | EP1240518A1 Markers for identification and isolation of pancreatic islet alpha and beta cell progenitors |
| 09/18/2002 | EP1240514A2 Biological sensor |
| 09/18/2002 | EP1240361A1 Method for detecting replication competent viruses in the sera of subjects receiving gene therapy |
| 09/18/2002 | EP1240360A2 Analysis of nucleotide polymorphisms at a site |
| 09/18/2002 | EP1240359A2 Method for selectively isolating a nucleic acid |
| 09/18/2002 | EP1240358A1 T1 receptor-like ligand ii and uses thereof |
| 09/18/2002 | EP1240356A2 Test system for detecting analytes, a method for the production thereof and its use |
| 09/18/2002 | EP1240355A1 Removal of dye-labeled dideoxy terminators from dna sequencing reactions |
| 09/18/2002 | EP1240354A2 Single nucleotide polymorphisms in genes |
| 09/18/2002 | EP1240353A2 Thin layer chromatographic detection of antibiotics |
| 09/18/2002 | EP1240352A2 Molecules derived from mechanism based drug design |
| 09/18/2002 | EP1240344A1 Replication incompetent herpes viruses for use in gene therapy |
| 09/18/2002 | EP1240335A2 Proteases |
| 09/18/2002 | EP1240331A2 i CHLAMYDIA /i ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 09/18/2002 | EP1240328A1 Antigenic protein lppq of mycoplasma mycoides subsp. mycoides sc., its preparation and use |
| 09/18/2002 | EP1240327A2 Interferon-like molecules and uses thereof |
| 09/18/2002 | EP1240326A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 09/18/2002 | EP1240324A2 Polypeptides and nucleic acids encoding same |
| 09/18/2002 | EP1240323A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 09/18/2002 | EP1240320A1 Nucleic acid isolation method and kit |
| 09/18/2002 | EP1240316A2 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells |
| 09/18/2002 | EP1240201A1 Oxidized apolipoproteins and methods of use |
| 09/18/2002 | EP1240197A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1240196A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 09/18/2002 | EP1240195A2 Polynucleotides and polypeptides encoded thereby |
| 09/18/2002 | EP1240194A2 Novel human protein kinases and protein kinase-like enzymes |
| 09/18/2002 | EP1240189A2 Hepatitis virus sentinel virus i (svi) |
| 09/18/2002 | EP1240183A2 Mammalian genes; related reagents and methods |
| 09/18/2002 | EP1240178A2 Methods and materials relating to prothrombinase-like polypeptides and polynucleotides |
| 09/18/2002 | EP1239964A1 Apparatus for performing heat-exchanging, chemical reactions |
| 09/18/2002 | EP1239950A2 Cell arrays and the uses thereof |
| 09/18/2002 | EP1239885A1 Interventions to mimic the effects of calorie restriction |
| 09/18/2002 | EP1239874A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 09/18/2002 | EP1239869A2 Tweak receptor |
| 09/18/2002 | EP1239848A2 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 09/18/2002 | EP1185711A4 Compositions and methods for labeling of nucleic acid molecules |
| 09/18/2002 | EP1088095A4 Novel molecules of the t110-related protein family and uses thereof |
| 09/18/2002 | EP1080227A4 A novel method of diagnosing, monitoring, and staging colon cancer |
| 09/18/2002 | EP1053352B1 Mismatch detection techniques |
| 09/18/2002 | EP0973943B1 Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes |
| 09/18/2002 | EP0954613B1 Reporter cell line system for detecting cytomegalovirus and identifying modulators of viral gene expression |
| 09/18/2002 | EP0950113B1 Detecting genetic predisposition to sight-threatening diabetic retinopathy |
| 09/18/2002 | EP0943015B1 Method and apparatus for preparing sample cartridges for a particle acceleration device |
| 09/18/2002 | EP0907750B1 Three-hybrid screening assay |
| 09/18/2002 | EP0859864B1 Method and apparatus for determining the existence of a mutation |
| 09/18/2002 | EP0810880B1 Pharmaceuticals and assays using enzyme subunits |
| 09/18/2002 | EP0789763B1 Icam-4 materials and methods |
| 09/18/2002 | EP0764217B1 Use of a specific marker for detecting Salmonella with PCR |
| 09/18/2002 | EP0750681B1 Assays for immunosuppressants |
| 09/18/2002 | EP0693936B1 Cloned leptospira outer membrane protein |
| 09/18/2002 | EP0654972B8 Method and apparatus for obtaining cytology monolayers |
| 09/18/2002 | CN2511687Y Time identifying fluorescent inspector for gene chip |
| 09/18/2002 | CN1370277A Method of diagnosis |
| 09/18/2002 | CN1370242A Genomic profiling: repid method for testing complex biological sample for presence of many types of organisms |
| 09/18/2002 | CN1370240A Regulation system of expression using nuclear PPAR receptors |
| 09/18/2002 | CN1370238A Human poly(ADP-ribose) polymerase 2 materials and methods |
| 09/18/2002 | CN1370233A ERS-genes, method of screening for chemical compounds capable of inducing ERS in plants |
| 09/18/2002 | CN1370231A CASB618 polynucleotides and polypeptides and their use |
| 09/18/2002 | CN1370230A Sumultaneous isolation and quantitation of DNA |
| 09/18/2002 | CN1370182A Compounds and methods for therapy and diagnosis of lung cancer |
| 09/18/2002 | CN1369709A Combined biochip and its preparing process |
| 09/18/2002 | CN1369699A Section staining method for tooth of odontoceti |
| 09/18/2002 | CN1091151C Common wild-rice near isogenic line resisting bacterial leaf-blight and its breeding process |
| 09/17/2002 | US6453245 Method and apparatus for identifying, classifying, or quantifying protein sequences in a sample without sequencing |
| 09/17/2002 | US6453244 Detection of polymorphisms by denaturing high-performance liquid chromatography |
| 09/17/2002 | US6453243 Method for displaying result of hybridization experiment using biochip and method for evaluating experimental error of hybridization experiment |
| 09/17/2002 | US6453242 Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| 09/17/2002 | US6452066 GENOMIC DNA FRAGMENTS CONTAINING REGULATORY AND CODING SEQUENCES FOR THE β2-SUBUNIT OF THE NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR AND TRANSGENIC ANIMALS MADE USING THESE FRAGMENTS OR MUTATED FRAGMENTS |
| 09/17/2002 | US6451997 Kits for detecting chromosomal rearrangements |
| 09/17/2002 | US6451996 Easily robotized using computers |
| 09/17/2002 | US6451994 Polypeptides, polynucleotides; drug screening; diagnosing alzheimer*s, parkinson*s, huntington*s, and creutzfelt-jacob disease; amyotrophic lateral sclerosis, cystic fibrosis |
| 09/17/2002 | US6451968 Hoogsteen type base pairing in triplex motif; diagnosis; heat resistance; detection of point mutations, restriction enzyme sites, and transcription inhibition |
| 09/17/2002 | US6451765 Methods for treating breast cancer using Mammastatin |
| 09/17/2002 | US6451760 Treatment of inflammation using a 2F1 polypeptide or an antibody thereto |
| 09/17/2002 | US6451598 Assaying whether a candidate agent inhibits fusion of an enveloped virion and its target cell; screening for anti-hiv agents |
| 09/17/2002 | US6451594 Adenovirus vector comprising transgene, cardiomyocyte restricted ankyrin repeat protein promoter, and inverted terminal repeat sequences from human adeno-associated virus |
| 09/17/2002 | US6451591 Device and method for the determination of protein domain boundaries |
| 09/17/2002 | US6451588 Collection of probes useful for hybridizing to a target nucleic acid. the probes associate with each other, binding with high affinity to the target nucleic acid, to form three-way junctions and other complexes and hybridization |
| 09/17/2002 | US6451582 Staphylococcus strains comprising an inducible gene encoding an RNA polymerase specificity factor |
| 09/17/2002 | US6451578 Hepatitis, amino acid sequences and nucleic acids |
| 09/17/2002 | US6451577 Human uridine disphosphate galactose-4-epimerase |
| 09/17/2002 | US6451575 The invention is directed to the family of aggrecan degrading metallo proteases (admps) that exhibit the ability to cleave the aggrecan core protein between amino acid residues glu.sup.373 -ala.sup.374. the invention encompasses the |
| 09/17/2002 | US6451573 Proteinase inhibitor, precursor thereof and genetic sequences encoding same |
| 09/17/2002 | US6451568 First cloning and expression, from a mammalian source, of proteins capable of catalyzing choline- and ethanolaminephosphotransferase reaction site-directed mutagenesis was used to differentiate the residues responsible |
| 09/17/2002 | US6451561 Growth hormone variants |
| 09/17/2002 | US6451555 Nucleic acid probes for detecting mutations and the methylation patterns of nucleic acids. the methods of the present invention are particularly useful for detecting and isolating genomic dna fragments which are near coding and |
| 09/17/2002 | US6451550 Haptoglobin assay |
| 09/17/2002 | US6451548 Methods for screening for specific inhibitors of trap and identifying compounds for treatment of diseases or conditions resulting in increased bone resorption using activated TRAP |